A systematic review investigating the identification, causes, and outcomes of delays in the management of chronic limb-threatening ischemia and diabetic foot ulceration
posted on 2019-08-12, 09:21authored byA Nickinson, B Bridgwood, J Houghton, S Nduwayo, C Pepper, T Payne, M Bown, RSM Davies, R Sayers
Objectives
Patients presenting with chronic limb threatening ischaemia (CLTI) and diabetic foot
ulceration (DFU) are at high risk of major lower limb amputation. Long-standing concern
exists regarding late presentation and delayed management contributing to increased
amputation rates. Despite multiple guidelines existing on the management of both conditions,
there is currently no accepted timeframe in which to enact specialist care and treatment. This
systematic review aims to investigate potential time delays in the identification, referral and
management of both CLTI and DFU.
Methods
A systematic review, conforming to the Preferred Reporting Items for Systematic Review of
Meta-Analysis (PRISMA) statement standards, was performed searching MEDLINE, Embase,
The Cochrane Library and CINAHL from inception to 14 13 th November 2018. All English
language qualitative and quantitative articles investigating or reporting the identification,
causes and outcomes of time delays within ‘high income’ countries (annual gross domestic
product per person >$15,000) were included. Data were extracted independently by the
investigators. Given the clinical cross-over, both conditions were investigated together. A study
protocol was designed and registered at the International Prospective Register of Systematic
Reviews (PROSPERO) (registration number: CRD42018115286).
Results
A total of 4780 articles were screened, of which 32 articles, involving 71,310 patients and
1,388 healthcare professionals were included. Twenty-three articles focussed predominantly
on DFU. Considerable heterogeneity was noted and only 12 articles were deemed of high
quality. Only 4 articles defined a ‘delay’ however this was not consistent between studies.
Median times from symptom onset to specialist healthcare assessment ranged from 15 to 126
days with subsequent median times from assessment to treatment ranging from 1 to 91 days.
A number of patient and healthcare factors were consistently reported as potentially causative
including, poor patient symptom recognition, inaccurate healthcare assessment and difficulties
in accessing specialist services. Twenty articles reported outcomes of delays, namely rates of
major amputation, ulcer healing and all-cause mortality. Although results were heterogeneous,
they elude to delays being associated with detrimental outcomes for patients.
Conclusions
Time delays exist in all aspects of the management pathway, which are in some cases
considerable in length. The causes of these are complex but reflect poor patient health-seeking
behaviours, inaccurate healthcare assessment and barriers to referral and treatment within the
care pathway. The adoption of standardised limits for referral and treatment times, exploration
of missed opportunities for diagnosis and investigation of novel strategies for providing
specialist care are required to help reduce delays.
Funding
AN, JSMH, SN and TP were funded through the George Davies Charitable Trust (Registered
18 Charity Number: 1024818). RS and BB are part funded by this Trust.
History
Citation
Journal of Vascular Surgery, Volume 71, Issue 2, February 2020, Pages 669-681.e2
Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Cardiovascular Sciences
The file associated with this record is under embargo until 12 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.